These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 37182159)

  • 1. Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphoma.
    Yang Y; Li Q; Ma J; Kang H; Lin Z; Wang Y; Ma Y; Chen B
    Front Oncol; 2023; 13():1098785. PubMed ID: 37182159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bruton's Tyrosine Kinase Inhibitors in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Meta-analysis and Systematic Review.
    Guo HP; Dang XL; Kang L; Liu C; Liu XW
    World Neurosurg; 2024 Aug; 188():161-169. PubMed ID: 38641241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Central Nervous System Lymphoma, Treatment Outcomes - 10 Year Experience. Single Center Study.
    Nizic A; Ibricevic-Balic L; Ceric T; Omerhodzic I; Burazerovic L; Saric V; Mameledzija E; Hasanefendic B
    Mater Sociomed; 2024; 36(1):23-25. PubMed ID: 38590596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology and treatment of primary central nervous system lymphoma.
    Algazi AP; Kadoch C; Rubenstein JL
    Neurotherapeutics; 2009 Jul; 6(3):587-97. PubMed ID: 19560747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zanubrutinib plus cytarabine in patients with refractory/relapsed primary central nervous system lymphoma.
    Lin Z; Ma J; Ma Y; Li Q; Kang H; Zhang M; Chen B
    Acta Haematol; 2024 Feb; ():. PubMed ID: 38408440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and prognosis of patients with newly diagnosed primary central nervous system lymphoma: a multicentre retrospective analysis.
    Bai SJ; He JX; Zheng YJ; Geng Y; Gao YN; Zhang CX; Wang YR; Qin LY; Wang WJ; Yang LH
    Ann Hematol; 2024 May; ():. PubMed ID: 38761184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of radiotherapy as salvage and/or consolidation treatment in relapsed/refractory and high-risk diffuse large B-cell lymphoma.
    Grignano E; Laurent J; Deau B; Burroni B; Bouscary D; Kirova YM
    Eur J Haematol; 2018 Apr; ():. PubMed ID: 29660176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: Successful treatment of a patient with relapsed/refractory primary central nervous system lymphoma with thiotepa-based induction, autologous stem cell transplantation and maintenance.
    Wang L; Fan Y; Chen B; Zhang J; Yang L; Qiu X; Jiang H; Li J; Xiao X; Huang L; Xu Y
    Front Oncol; 2023; 13():1333761. PubMed ID: 38348121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma.
    Yonezawa H; Narita Y; Nagane M; Mishima K; Terui Y; Arakawa Y; Asai K; Fukuhara N; Sugiyama K; Shinojima N; Aoi A; Nishikawa R
    Neurooncol Adv; 2024; 6(1):vdae037. PubMed ID: 38690230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of comorbidity indices and histochemical markers in surgically resected and non-resected primary central nervous system lymphoma.
    Wong CE; Liao WA; Chang Y; Lee PH; Huang CC; Chang KC; Lee JS
    Clin Exp Med; 2023 Nov; 23(7):3799-3807. PubMed ID: 37491648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates of primary central nervous system lymphoma.
    Wu J; Zhou D; Zhu X; Zhang Y; Xiao Y
    Ther Adv Hematol; 2024; 15():20406207241259010. PubMed ID: 38883164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase II study assessing Long-Term Response to Ibrutinib Monotherapy in recurrent or refractory CNS Lymphoma.
    Grommes C; Nandakumar S; Schaff LR; Gavrilovic I; Kaley TJ; Nolan CP; Stone J; Thomas AA; Tang SS; Wolfe J; Bozza A; Wongchai V; Hyde A; Barrett E; Lynch EA; Madzsar JT; Lin A; Piotrowski AF; Pentsova E; Francis JH; Hatzoglou V; Schultz N; Reiner AS; Panageas KS; DeAngelis LM; Mellinghoff IK
    Clin Cancer Res; 2024 Jul; ():. PubMed ID: 38995739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and Relapse Patterns in Primary Central Nervous System Lymphoma: Longitudinal Analysis of 559 Patients Diagnosed From 1983-2020.
    Tringale KR; Scordo M; Yahalom J; White C; Zhang Z; Vachha B; Cederquist G; Schaff L; DeAngelis L; Grommes C; Imber BS
    Neuro Oncol; 2024 Jun; ():. PubMed ID: 38915246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical resection versus biopsy in the treatment of primary central nervous system lymphoma: a systematic review and meta-analysis.
    Chojak R; Koźba-Gosztyła M; Polańska K; Rojek M; Chojko A; Bogacz R; Skorupa N; Więcław J; Czapiga B
    J Neurooncol; 2022 Dec; 160(3):753-761. PubMed ID: 36449256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival outcomes and treatment experience of 124 patients with primary central nervous system lymphoma.
    Tang Z; Wu G; Tan F; Long Y; Hong J; Lyu Z; Wei R
    Strahlenther Onkol; 2024 Mar; ():. PubMed ID: 38466403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal miR-200c and miR-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma.
    Hu Y; Zhang Q; Wu Z; Chen K; Xu X; Ma W; Chen B; Jin L; Guan M
    Discov Oncol; 2023 Nov; 14(1):205. PubMed ID: 37971595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of interleukin-10 concentration in the cerebrospinal fluid of patients with primary central nervous system lymphoma.
    Geng M; Song Y; Xiao H; Wu Z; Deng X; Chen C; Wang G
    Oncol Lett; 2021 Jan; 21(1):2. PubMed ID: 33240408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microscopic biopsy after unsuccessful endoscopic biopsy for primary central nervous system lymphoma of the corpus callosum: A case report.
    Kanazawa T; Karatsu K; Kuramae T; Ishihara M
    Ann Med Surg (Lond); 2021 Sep; 69():102746. PubMed ID: 34471530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a contacting transwell co-culture system for the
    Nishi M; Tateishi K; Sundararaj JS; Ino Y; Nakai Y; Hatayama Y; Yamaoka Y; Mihana Y; Miyakawa K; Kimura H; Kimura Y; Yamamoto T; Ryo A
    Front Cell Dev Biol; 2023; 11():1275519. PubMed ID: 38089883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European survey on neurosurgical management of primary central nervous system lymphomas and preoperative corticosteroid therapy.
    Scheichel F; Popadic B; Pinggera D; Jaskolski DJ; Lubrano V; Foroglou N; Netuka D; Iliescu B; Novak L; Sherif C; Marhold F; Freyschlag CF
    Brain Spine; 2023; 3():101791. PubMed ID: 38020980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.